These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results. Mane I, Cartel JL, Grosset JH. Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595 [Abstract] [Full Text] [Related]
4. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion. Majumder V, Saha B, Hajra SK, Biswas SK, Saha K. Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091 [Abstract] [Full Text] [Related]
9. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India. Kumar A, Girdhar A, Girdhar BK. Indian J Dermatol Venereol Leprol; 2015 Sep; 81(4):356-62. PubMed ID: 26144850 [Abstract] [Full Text] [Related]
11. Delayed resolution versus treatment failure in paucibacillary leprosy patients under six months fixed duration multidrug therapy. Job CK, Jayakumar J, Aschhoff M. Indian J Lepr; 1997 Sep; 69(2):131-42. PubMed ID: 9290964 [Abstract] [Full Text] [Related]
12. A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand; a prospective study, 1984-1996. Dasananjali K, Schreuder PA, Pirayavaraporn C. Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):28-36. PubMed ID: 9207751 [Abstract] [Full Text] [Related]
14. Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up. Rao PN, Suneetha S, Pratap DV. Lepr Rev; 2011 Sep; 82(3):244-52. PubMed ID: 22125932 [Abstract] [Full Text] [Related]